GNBT running hard this morning. Hit 3.11/share in pre-market trading so far. Enjoy it.
I see that they reported earnings, claiming that their losses widened as a result of interest on convertible debentures.
This has not hit the wires like Yahoo, where I normally look for PR releases:
DJ Generex Biotechnology 2Q Loss Widens To 23c/Share >GNBT
WASHINGTON (Dow Jones)--Generex Biotechnology Corp. (GNBT) on Thursday said its second-quarter loss widened to $14.4 million, or 23 cents a share, from $6.3 million, or 18 cents a share, in the same period a year ago.
The Toronto-based biotechnology company cited in a quarterly report filed with the Securities and Exchange Commission the increase in the loss for second quarter ended Jan. 31. It said the result was because of an increase in interest expense incurred in connection with convertible debentures.
Generex Biotechnology reported second-quarter revenue of 43,750, compared with $76,750 in the prior year's second quarter.
-By Gee L. Lee, Dow Jones Newswires; 202-862-1346
(END) Dow Jones Newswires
March 16, 2006 11:38 ET (16:38 GMT)
Copyright (c) 2006 Dow Jones & Company, Inc.- - 11 38 AM EST 03-16-06 |
